BACKGROUND: Merkel cell carcinoma (MCC) is an uncommon, highly aggressive skin malignancy with a propensity to recur locally and regionally. However, its optimal treatment is uncertain. In this study, we aimed to assess the roles of lymphoscintigraphy and sentinel node (SN) biopsy, as well as radiotherapy, in the treatment of MCC. PATIENTS AND METHODS: A retrospective analysis of 17 patients diagnosed with MCC (median age 74 years) over a 7-year period (median follow-up 16 months) was performed. RESULTS: Of 11 patients. 3 had a positive SN biopsy and, despite adjuvant radiotherapy, 2 of these 3 developed regional lymph node (RLN) recurrence. Of the remaining 8 patients who had a negative SN biopsy, however, 5 also had RLN recurrences. There were 9 patients who received adjuvant radiotherapy (RT) to the primary site, with no in-field recurrences; and 8 who received RT to their RLN field, with only 2 developing regional nodal recurrences-both were SN biopsy positive. During the follow-up period, 2 patients died, only 1 due to MCC. CONCLUSION: The results suggest that SN status may not be an accurate predictor of loco-regional recurrence in MCC. However, they strongly reinforce previous reports that radiotherapy, both locally and to regional nodes, provides effective infield disease control.
BACKGROUND:Merkel cell carcinoma (MCC) is an uncommon, highly aggressive skin malignancy with a propensity to recur locally and regionally. However, its optimal treatment is uncertain. In this study, we aimed to assess the roles of lymphoscintigraphy and sentinel node (SN) biopsy, as well as radiotherapy, in the treatment of MCC. PATIENTS AND METHODS: A retrospective analysis of 17 patients diagnosed with MCC (median age 74 years) over a 7-year period (median follow-up 16 months) was performed. RESULTS: Of 11 patients. 3 had a positive SN biopsy and, despite adjuvant radiotherapy, 2 of these 3 developed regional lymph node (RLN) recurrence. Of the remaining 8 patients who had a negative SN biopsy, however, 5 also had RLN recurrences. There were 9 patients who received adjuvant radiotherapy (RT) to the primary site, with no in-field recurrences; and 8 who received RT to their RLN field, with only 2 developing regional nodal recurrences-both were SN biopsy positive. During the follow-up period, 2 patients died, only 1 due to MCC. CONCLUSION: The results suggest that SN status may not be an accurate predictor of loco-regional recurrence in MCC. However, they strongly reinforce previous reports that radiotherapy, both locally and to regional nodes, provides effective infield disease control.
Authors: Franz O Smith; Binglin Yue; Suroosh S Marzban; Brooke L Walls; Michael Carr; Ryan S Jackson; Christopher A Puleo; Tapan Padhya; C Wayne Cruse; Ricardo J Gonzalez; Amod A Sarnaik; Michael J Schell; Ronald C DeConti; Jane L Messina; Vernon K Sondak; Jonathan S Zager Journal: Cancer Date: 2015-06-02 Impact factor: 6.860
Authors: Ryan C Fields; Klaus J Busam; Joanne F Chou; Katherine S Panageas; Melissa P Pulitzer; Dennis H Kraus; Mary S Brady; Daniel G Coit Journal: Ann Surg Oncol Date: 2011-03-24 Impact factor: 5.344
Authors: Maryam M Asgari; Monica M Sokil; E Margaret Warton; Jayasri Iyer; Kelly G Paulson; Paul Nghiem Journal: JAMA Dermatol Date: 2014-07 Impact factor: 10.282
Authors: Patricia Tai; Edward Yu; Avi Assouline; Ji Dong Lian; Kurian Joseph; Thomas Miale; Claude Krzisch Journal: Med Oncol Date: 2009-12-01 Impact factor: 3.064
Authors: Ferdinand C A Timmer; W M C Klop; Germaine N Relyveld; Marianne B Crijns; A J M Balm; Michiel W M van den Brekel; Peter J F M Lohuis Journal: Eur Arch Otorhinolaryngol Date: 2015-03-11 Impact factor: 2.503
Authors: Jennifer S Ko; Victor G Prieto; Paul J Elson; Ricardo E Vilain; Melissa P Pulitzer; Richard A Scolyer; Jordan P Reynolds; Melissa P Piliang; Marc S Ernstoff; Brian R Gastman; Steven D Billings Journal: Mod Pathol Date: 2015-11-06 Impact factor: 7.842